Pharmacy Valuation Multiples (2026)
Pharmacy multiples reward compounding, LTC, and specialty Rx work that lifts gross margin. Standard retail dispensing trades around 0.4× revenue with margin pressure from DIR fees.
Lookup my business multiple
Pick your industry and enter revenue + EBITDA / SDE. We'll triangulate three valuation methods and show what buyers typically pay for businesses like yours.
Premium drivers
- ↑Compounding / specialty Rx revenue
- ↑Strong PBM contracts and DIR fee profile
- ↑Front-end retail sales > 20%
- ↑Long-term care or LTC partnerships
Discount drivers
- ↓DIR fee exposure / margin compression
- ↓Single PBM concentration
- ↓Generic-only Rx mix
- ↓Lease near expiration
Who buys pharmacy?
Independent pharmacy buyer, regional independent group, or chain (CVS, Walgreens, regional)
Typical timeline + revenue band
- Days to close: 90–180
- Revenue band these multiples apply to: $2.00M–$8.00M
- NAICS: 446110 (Healthcare)
5 levers that lift your Pharmacy multiple by 30-50%
- 1Lock in recurring revenueConvert the top of your pharmacy revenue stack into multi-year contracts, retainers, or auto-renewing subscriptions. Buyers pay 25-40% more for revenue they don't have to re-win every quarter.
- 2De-risk customer concentrationAim for no single customer above 15% of revenue. If you have a > 25% client, get them on a multi-year master services agreement before going to market.
- 3Document the business out of the ownerIndependent pharmacy buyer, regional independent group, or chain (CVS, Walgreens, regional) will discount aggressively for any function that lives in the owner's head — sales, key vendor relationships, pricing, hiring. Run the next 90 days like the owner is on a 6-week vacation.
- 4Clean up the financialsGet a Quality of Earnings-ready trailing 12 months: GAAP-aligned, owner add-backs documented, no commingled personal expenses. This alone moves the multiple 0.5-1.0× upward in this category.
- 5Match the deal to the right buyer poolstrategic acquirers and operator buyers compete on different terms. List with someone who has run a process for pharmacy acquisitions — generic SMB brokers will leave 20%+ on the table.
FAQ — Pharmacy valuations
What's a typical pharmacy valuation multiple?▾
Typical pharmacy valuations land near 3.5× SDE, 5× EBITDA, or 0.4× revenue. Strong operators reach 4.5× SDE / 6.5× EBITDA / 0.55× revenue, while weaker operators stay closer to 2.8× SDE / 4× EBITDA / 0.3× revenue.
How long does it take to sell a pharmacy?▾
Most pharmacy deals close in 90–180 days from listing. Strong operators with clean financials and a documented buyer pool close on the lower end.
Who buys a pharmacy business?▾
Independent pharmacy buyer, regional independent group, or chain (CVS, Walgreens, regional)
What pushes a pharmacy valuation to the high end?▾
Compounding / specialty Rx revenue. Strong PBM contracts and DIR fee profile. Front-end retail sales > 20%. Long-term care or LTC partnerships.
What forces a discount when selling a pharmacy?▾
DIR fee exposure / margin compression. Single PBM concentration. Generic-only Rx mix. Lease near expiration.